Ribociclib Market Key Drivers and Forecast 2025-2032

Ribociclib Market Trends And Drivers The Ribociclib market was valued at USD 1.73 billion in 2022 and is projected to reach USD 3.90 billion by 2030, growing at a CAGR of 10.5% from 2024 to 2030. The increasing prevalence of breast cancer, particularly HR-positive and HER2-negative subtypes, is driving the demand for targeted therapies like […]

Continue Reading